VANIQA DRUG INFO
Buy Vaniqa for less!
Review the below information carefully as it is intended to supplement, not substitute
for, the expertise and judgment of your physician, pharmacist or
other healthcare professional. It should not be construed to indicate
that use of the drug is safe, appropriate, or effective for you.
Consult your healthcare professional before using this medication.
EFLORNITHINE - TOPICAL (eh-FLOOR-nith-een)
COMMON BRAND NAME(S): Vaniqa
medication is used to slow down the growth of unwanted facial hair
in females. It works via the interference of an enzyme within the skin that's necessary for hair
growth, but does not remove hair. This drug is not for use in children who are
under the age of 12.
HOW SHOULD I USE VANIQA?:
- Apply eflornithine topical exactly as directed by your doctor. If you do not understand these directions, ask your doctor or pharmacist.
- Eflornithine topical does not permanently remove hair. Nor is it a hair remover (depilatory). You will need to continue using your current hair removal techniques. Eflornithine topical will help you manage your condition and improve your appearance.
- Vaniqa topical is designed exclusively for external use.
- Vaniqa is typically applied twice daily, at least eight hours apart, or as directed by your doctor.
- Wash your hands before and after each application of eflornithine topical.
- Remove any facial hair that is present using your current hair removal techniques. Wait at least 5 minutes after hair removal before applying eflornithine topical. Apply a thin layer of eflornithine topical to the affected areas of the face and nearby affected areas under the chin and rub it in thoroughly.
- Cosmetics or sunscreen may be used after applying eflornithine topical, but you should leave several minutes inbetween applications to allow treatment to be absorbed before applying them.
- Avoid washing the treatment area for at least 4 hours after application of eflornithine topical.
- Avoid getting this medication in your eyes, nose, or mouth. If this occurs, wash the area with water. If Vaniqa in your eyes, rinse them thoroughly with water and contact your doctor.
- Eflornithine topical may cause temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application of eflornithine topical to once a day. If irritation continues, stop using eflornithine topical and contact your doctor.
- Continue with the regular Vaniqa even if you do not see immediate results. Reduction in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment with eflornithine topical should be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment with eflornithine topical.
Rash, burning, stinging, tingling, or redness of the skin, or "hair
bumps" (folliculitis) may occur. If these effects persist or
worsen, notify your physician immediately. Tell your doctor if you
develop any of these serious side effects while using Vaniqa: bleeding skin, swelling
of the face or lips, as they may be indicative of an adverse allergic reaction. If you notice other effects not listed above,
contact your doctor or pharmacist.
Tell your doctor your medical history, including: allergies, broken
skin, sores on the face. This medication should be used only when
clearly needed during pregnancy. Discuss the risks and benefits
with your doctor. It is currently unknown whether or not this drug passes into
breast milk. Consult your doctor before feeding your baby with breast milk.
DRUG INTERACTIONS: Tell
your doctor of all prescription and nonprescription medication you
may use, especially of: other facial or skin products. Do not start
or stop any medicine without doctor or pharmacist approval.
If overdose of Vaniqa is suspected, contact your local poison control center
or emergency room right away. This medicine may be harmful if ingested in significant amounts.
Symptoms following ingestion may include hair loss, facial swelling,
seizures, hearing loss, upset stomach, loss of appetite, headache,
weakness, and dizziness.
not share this or other medications with others.
MISSED DOSE: If
you miss or forget a dose, do not make it up. Instead, skip the
missed dose and resume your usual dosing schedule. Do not double or increase
the dose to catch up.
Store at controlled room temperature (77 degrees F or 25 degrees
C). Brief storage between 59 and 86 degrees F (15 to 30 degrees
C) is permitted. Vaniqa should not be exposed to very cold or freezing temperatures.